Still waiting to hear about Stephen's last prometheus test and not expecting any issues but, as we've already had to increase the frequency once, I'd like some info upfront. I feel like I'm always one step behind and end up doing 'catch up' research AFTER decisions are made. :ybatty:
So my questions... if this last prometheus test shows that remicade levels are zero, and assuming also zero on antibodies, the GI would have two options relating to remicade - increase the frequency to 5 or 4 week intervals or increase his dosage (he's currently on 5mg).
Would this be a reason to add an immunosuppressant? ie would that help maintain remicade levels during the full six weeks?
What determines whether the dosage is increased or the frequency increased? Is anyone aware of any info illustrating that one choice is more successful than the other?
Also, is the dosage always upped from 5 to 10mg (which I believe is the max dosage)? Or are smaller increments used when increasing?
Thanks
So my questions... if this last prometheus test shows that remicade levels are zero, and assuming also zero on antibodies, the GI would have two options relating to remicade - increase the frequency to 5 or 4 week intervals or increase his dosage (he's currently on 5mg).
Would this be a reason to add an immunosuppressant? ie would that help maintain remicade levels during the full six weeks?
What determines whether the dosage is increased or the frequency increased? Is anyone aware of any info illustrating that one choice is more successful than the other?
Also, is the dosage always upped from 5 to 10mg (which I believe is the max dosage)? Or are smaller increments used when increasing?
Thanks